Dentsply Sirona — Q3 2026 Earnings Summary

Dentsply Sirona reported third-quarter 2026 net sales of $836 million, representing a 7.6% decline from the prior year period. The company posted a GAAP diluted loss per share of $0.01, while adjusted earnings per share were $0.29 with an adjusted EBITDA margin of 17.3%. Wellspect Healthcare achieved record quarterly sales with 10.1% growth, and the company launched the Surity Urinary Management System in the U.S. Management updated its full-year 2026 outlook to approximately $3.5 billion in net sales and adjusted earnings per share between $1.20 and $1.30.